Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

Tofacitinib and Other Kinase Inhibitors Offer New Approach to Treating Rheumatoid Arthritis

Deborah L. Parks, MD  |  June 1, 2013

Small molecule kinase inhibitors, such as JAK inhibitors, provide a novel route for rheumatic disease treatment—and may promote our understanding of the immune system’s complexities

Filed under:Biologics/DMARDsConditionsDrug UpdatesRheumatoid Arthritis Tagged with:JAK inhibitorsRARheumatic DiseaseRheumatoid arthritisTofacitinibTreatment

What Rheumatologists Need to Know about Identifying Amyloidosis

Neil Canavan  |  June 1, 2013

Although amyloidosis is not a rheumatic disease, rheumatologists may be the first to diagnose this life-threatening condition

Filed under:Conditions Tagged with:AmyloidosisDiagnosispatient care

Advances in Genomics, Bioinformatics Draw New Insights From the Human Genome

Sheri M. Krams, PhD, and Jonathan S. Bromberg, MD, PhD  |  June 1, 2013

Widely held belief that large segments of the human genome consist of ‘junk DNA’ is incorrect, say scientists

Filed under:Research Rheum Tagged with:bioinformaticsResearch

A Rheumatologist’s Tips for Tweeting and Blogging

Carol Patton  |  June 1, 2013

Paul Sufka, MD, networks almost daily with physicians worldwide about new medical approaches, research, or treatments

Filed under:Technology Tagged with:rheumatologySocial MediaTechnology

Researcher Studies Ways to Cut Cardiovascular Disease Risk in Rheumatoid Arthritis Patients

Staff  |  June 1, 2013

Better communication and more proactive partnerships between rheumatologists and primary care physicians may help modify CVD risk factors for patients with rheumatoid arthritis

Filed under:From the College Tagged with:Cardiovascular diseasepatient communicationRARheumatoid arthritis

President’s Perspective: The ACR Creates Strategic Plan to Advance Rheumatology

Audrey B. Uknis, MD  |  June 1, 2013

ACR’s strategy for 2013-2016 includes advocacy efforts, educational programming and journals, and rheumatology research support

Filed under:President's Perspective Tagged with:AC&RAdvocacyEducationrheumatology

PR-COIN Initiative Takes Aim at Juvenile Idiopathic Arthritis

Mary Beth Nierengarten  |  June 1, 2013

The Pediatric Rheumatology Care and Outcomes Improvement Network uses clinical evidence and a network of collaborators to improve outcomes for children with JIA

Filed under:ConditionsPediatric Conditions Tagged with:JIAJuvenile idiopathic arthritispatient outcomePediatric

Rheuminations: Circadian Rhythms May Play Role in Inflammatory Disease

Simon M. Helfgott, MD  |  May 1, 2013

Research into how the timing of light and dark exposures control our lives could provide clues to why some people have immunologic disorders

Filed under:OpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:Inflammatory DiseaseResearchrheumatology

ACR Winter Rheumatology Symposium: New Kinase Inhibitors Show Promise

Staff  |  May 1, 2013

Toxicity and appropriate targeting are challenges for small molecule researchers

Filed under:Drug UpdatesMeeting ReportsResearch Rheum Tagged with:AC&RACR Winter Rheumatology Symposiumkinase inhibitorResearch

Fellow’s Forum Case Report: Diagnosing Antisynthetase Syndrome

Fawad Aslam, MBBS, and Elizabeth B. Russell, MD  |  May 1, 2013

A variable combination of interstitial lung disease, myopathy, fever, joint involvement, and mechanic’s hands characterize this systemic autoimmune syndrome

Filed under:ConditionsOther Rheumatic Conditions Tagged with:Antisynthetase SyndromeInterstitial Lung Diseasepatient care

  • « Previous Page
  • 1
  • …
  • 99
  • 100
  • 101
  • 102
  • 103
  • …
  • 125
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences